These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36889122)

  • 1. Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
    Kelberman MA; Rorabaugh JM; Anderson CR; Marriott A; DePuy SD; Rasmussen K; McCann KE; Weiss JM; Weinshenker D
    Neurobiol Aging; 2023 May; 125():98-108. PubMed ID: 36889122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
    Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
    J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.
    Kelberman MA; Anderson CR; Chlan E; Rorabaugh JM; McCann KE; Weinshenker D
    J Alzheimers Dis; 2022; 86(3):1037-1059. PubMed ID: 35147547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.
    Kelly SC; McKay EC; Beck JS; Collier TJ; Dorrance AM; Counts SE
    J Alzheimers Dis; 2019; 70(2):371-388. PubMed ID: 31177220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
    Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
    Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
    Pamphlett R; Kum Jew S
    J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.
    Chalermpalanupap T; Weinshenker D; Rorabaugh JM
    Neural Plast; 2017; 2017():7829507. PubMed ID: 29038736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.
    Sakakibara Y; Hirota Y; Ibaraki K; Takei K; Chikamatsu S; Tsubokawa Y; Saito T; Saido TC; Sekiya M; Iijima KM
    J Alzheimers Dis; 2021; 82(4):1513-1530. PubMed ID: 34180416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
    Satoh A; Iijima KM
    Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower in vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer's pathology: a cohort study.
    Engels-Domínguez N; Koops EA; Hsieh S; Wiklund EE; Schultz AP; Riphagen JM; Prokopiou PC; Hanseeuw BJ; Rentz DM; Sperling RA; Johnson KA; Jacobs HIL
    Alzheimers Res Ther; 2024 Jun; 16(1):129. PubMed ID: 38886798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.
    Morrone CD; Lai AY; Bishay J; Hill ME; McLaurin J
    Transl Neurodegener; 2022 May; 11(1):26. PubMed ID: 35501886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease.
    Flores-Aguilar L; Hall H; Orciani C; Foret MK; Kovecses O; Ducatenzeiler A; Cuello AC
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12835. PubMed ID: 35822518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease.
    Ehrenberg AJ; Nguy AK; Theofilas P; Dunlop S; Suemoto CK; Di Lorenzo Alho AT; Leite RP; Diehl Rodriguez R; Mejia MB; Rüb U; Farfel JM; de Lucena Ferretti-Rebustini RE; Nascimento CF; Nitrini R; Pasquallucci CA; Jacob-Filho W; Miller B; Seeley WW; Heinsen H; Grinberg LT
    Neuropathol Appl Neurobiol; 2017 Aug; 43(5):393-408. PubMed ID: 28117917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome.
    Saternos H; Hamlett ED; Guzman S; Head E; Granholm AC; Ledreux A
    J Alzheimers Dis; 2024; 101(2):541-561. PubMed ID: 39213062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence in support of a prodromal respiratory control signature in the TgF344-AD rat model of Alzheimer's disease.
    Lucking EF; Murphy KH; Burns DP; Jaisimha AV; Barry-Murphy KJ; Dhaliwal P; Boland B; Rae MG; O'Halloran KD
    Respir Physiol Neurobiol; 2019 Jul; 265():55-67. PubMed ID: 29969703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.
    Cohen RM; Rezai-Zadeh K; Weitz TM; Rentsendorj A; Gate D; Spivak I; Bholat Y; Vasilevko V; Glabe CG; Breunig JJ; Rakic P; Davtyan H; Agadjanyan MG; Kepe V; Barrio JR; Bannykh S; Szekely CA; Pechnick RN; Town T
    J Neurosci; 2013 Apr; 33(15):6245-56. PubMed ID: 23575824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer's disease.
    Khan KM; Balasubramanian N; Gaudencio G; Wang R; Selvakumar GP; Kolling L; Pierson S; Tadinada SM; Abel T; Hefti M; Marcinkiewcz CA
    Acta Neuropathol Commun; 2023 Apr; 11(1):57. PubMed ID: 37009893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.